- Home
- NWBI vs QDEL Comparison
NWBI vs QDEL Comparison
Compare NWBI & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWBI
- QDEL
- Stock Information
- Founded
- NWBI 1896
- QDEL 1979
- Country
- NWBI United States
- QDEL United States
- Employees
- NWBI N/A
- QDEL N/A
- Industry
- NWBI Major Banks
- QDEL Medical Specialities
- Sector
- NWBI Finance
- QDEL Health Care
- Exchange
- NWBI Nasdaq
- QDEL Nasdaq
- Market Cap
- NWBI 1.8B
- QDEL 2.1B
- IPO Year
- NWBI N/A
- QDEL N/A
- Fundamental
- Price
- NWBI $12.47
- QDEL $27.83
- Analyst Decision
- NWBI Hold
- QDEL Hold
- Analyst Count
- NWBI 1
- QDEL 6
- Target Price
- NWBI $15.00
- QDEL $39.00
- AVG Volume (30 Days)
- NWBI 845.6K
- QDEL 1.4M
- Earning Date
- NWBI 10-27-2025
- QDEL 11-06-2025
- Dividend Yield
- NWBI 6.42%
- QDEL N/A
- EPS Growth
- NWBI 39.35
- QDEL N/A
- EPS
- NWBI 1.12
- QDEL N/A
- Revenue
- NWBI $561,855,000.00
- QDEL $2,741,600,000.00
- Revenue This Year
- NWBI $6.98
- QDEL N/A
- Revenue Next Year
- NWBI $11.67
- QDEL $2.93
- P/E Ratio
- NWBI $11.13
- QDEL N/A
- Revenue Growth
- NWBI 14.22
- QDEL N/A
- 52 Week Low
- NWBI $10.75
- QDEL $22.05
- 52 Week High
- NWBI $15.42
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- NWBI 50.01
- QDEL 47.98
- Support Level
- NWBI $12.32
- QDEL $25.95
- Resistance Level
- NWBI $12.80
- QDEL $32.81
- Average True Range (ATR)
- NWBI 0.22
- QDEL 1.44
- MACD
- NWBI -0.00
- QDEL -0.01
- Stochastic Oscillator
- NWBI 39.47
- QDEL 30.64
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.